Sunday, 21 April 2019

Dr. Reddy's launches Tadalafil Tablets in US

12 February 2019 | News

It is a therapeutic equivalent generic version of Adcirca

Dr. Reddy’s Laboratories has announced the launch of Tadalafil Tablets USP, a therapeutic equivalent generic version of Adcirca (tadalafil) Tablets in the United States market, approved by the U.S. Food and Drug Administration (USFDA).

The Adcirca brand and generic had U.S. sales of approximately $490 million MAT for the most recent twelve months ending in November 2018 according to IMS Health.

Dr. Reddy’s Tadalafil Tablets are available in 20 mg with 60 count bottle size. Adcirca is a trademark of Eli Lilly and Company.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account

Podcast

 

Survey Box

Can data align the pharma industry with healthcare better?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls